Login / Signup

Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.

Young-Jun ChoiJae-Hui NamJung Yup KimJoon Hong MinKui Young ParkEun Jung KoBeom Joon KimWon-Serk Kim
Published in: Lasers in surgery and medicine (2017)
A 750 picosecond laser using 1 064 and 595 nm was effective and safe for the treatment of Korean melasma patients. The picosecond laser with dual-wavelength used in this study can reduce the photothermal effect generated during the removal of pigment and total duration of the procedure, and can be expected to reduce the occurrence of adverse events. Lasers Surg. Med. 49:899-907, 2017. © 2017 Wiley Periodicals, Inc.
Keyphrases
  • clinical trial
  • photodynamic therapy
  • end stage renal disease
  • ejection fraction
  • newly diagnosed
  • high speed
  • chronic kidney disease
  • double blind
  • patient reported outcomes
  • high resolution